| Date Filed | Type | Description |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2023 |
4
| Telman Deborah H (Director) has filed a Form 4 on AtriCure, Inc.|
Txns:
| Granted 3,186 shares
@ $0 |
|
| 03/13/2023 |
4
| Telman Deborah H (EVP, Corporate Affairs & GC) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 10,220 restricted stock units
@ $0
Granted 46,605 options to buy
@ $79.5, valued at
$3.7M
|
|
| 02/23/2023 |
4
| Telman Deborah H (EVP, Corporate Affairs & GC) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 376 shares
@ $56.3805, valued at
$21.2k
|
|
| 08/05/2022 |
3
| Telman Deborah H (EVP, Corporate Affairs & GC) has filed a Form 3 on GILEAD SCIENCES, INC. |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Telman Deborah H (EVP GC & Corporate Secretary) has filed a Form 4 on Organon & Co.|
Txns:
| Paid exercise price by delivering 1,299 shares
@ $32.44, valued at
$42.1k
Exercised 4,431 restricted stock units
@ $0 |
|
| 04/04/2022 |
4
| Telman Deborah H (Gen Counsel & Corp Sec) has filed a Form 4 on Organon & Co.|
Txns:
| Granted 12,882 restricted stock units
@ $0
Granted 39,682 options to buy
@ $34.93, valued at
$1.4M
|
|
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |